| Scrip code | 000000 |
|---|---|
| NSE Symbol | NEPHROCARE |
| MSEI Symbol | NA |
| ISIN | INE0SUN01013 |
| Name of Company | NEPHRO CARE INDIA LIMITED |
| Type of company | SME |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 07-08-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 27-07-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | First quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 07-08-2026 16:00:00 |
| End date and time of board meeting | 07-08-2026 17:00:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-06-2026 | 30-06-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Revenue From Operations | ||
| Revenue from operations | 2,918.52 | 2,918.52 | |
| Other income | 22.32 | 22.32 | |
| Total Income | 2,940.84 | 2,940.84 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 975.81 | 975.81 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (76.82) | (76.82) |
| (d) | Employee benefit expense | 404.06 | 404.06 |
| (e) | Finance costs | 3.46 | 3.46 |
| (f) | Depreciation and amortisation expense | 119.35 | 119.35 |
| (g) | Other Expenses | ||
| 1 | Other Expenses | 1,253.82 | 1,253.82 |
| Total other expenses | 1,253.82 | 1,253.82 | |
| Total expenses | 2,679.68 | 2,679.68 | |
| 3 | Profit before exceptional and extraordinary items and tax | 261.16 | 261.16 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Profit before extraordinary items and tax | 261.16 | 261.16 |
| 6 | Extraordinary items | 0.00 | 0.00 |
| 7 | Profit before tax | 261.16 | 261.16 |
| 8 | Tax Expense | ||
| Current tax | 114.13 | 114.13 | |
| Deferred tax | (13.76) | (13.76) | |
| Total tax expenses | 100.37 | 100.37 | |
| 9 | Net Profit Loss for the period from continuing operations | 160.79 | 160.79 |
| 10 | Profit (loss) from discontinuing operations before tax | 0.00 | 0.00 |
| 11 | Tax expense of discontinuing operations | 0.00 | 0.00 |
| 12 | Net profit (loss) from discontinuing operation after tax | 0.00 | 0.00 |
| 13 | Profit (loss) for period before minority interest | 160.79 | 160.79 |
| 14 | Share of profit (loss) of associates | 0.00 | 0.00 |
| 15 | Profit (loss) of minority interest | 0.00 | 0.00 |
| 16 | Net profit (Loss) for the period | 160.79 | 160.79 |
| 17 | Details of equity share capital | ||
| Paid-up equity share capital | 1,648.64 | 1,648.64 | |
| Face value of equity share capital | 10 | 10 | |
| 18 | Reserves excluding revaluation reserve | ||
| 19 | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 0.98 | 0.98 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0.98 | 0.98 | |
| 20 | Debt equity ratio | ||
| 21 | Debt service coverage ratio | ||
| 22 | Interest service coverage ratio | ||
| 23 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) |
|---|
| 20 | Debt equity ratio | |
|---|---|---|
| 21 | Debt service coverage ratio | |
| 22 | Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-06-2026 | 30-06-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Income from IPD Services | 1,565.30 | 1,565.30 | ||||
| 2 | Income from OPD Services | 758.31 | 758.31 | ||||
| 3 | Income from sale of medicines from pharmacy | 594.91 | 594.91 | ||||
| 4 | Add: Profit on Sale of Investment | 3.96 | 3.96 | ||||
| 5 | Add: Interest Income | 5.42 | 5.42 | ||||
| 6 | Add: Dialysis machine Rental charges | 1.32 | 1.32 | ||||
| 7 | Add: Others | 11.62 | 11.62 | ||||
| Total Segment Revenue | 2,940.84 | 2,940.84 | |||||
| Less: Inter segment revenue | 329.38 | 329.38 | |||||
| Revenue from operations | 2,611.46 | 2,611.46 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Income from IPD Services | 1,006.34 | 1,006.34 | ||||
| 2 | Income from OPD Services | 578.24 | 578.24 | ||||
| 3 | Income from sale of medicines from pharmacy | 96.93 | 96.93 | ||||
| 4 | Add: Profit on Sale of Investment | 0.00 | 0.00 | ||||
| 5 | Add: Interest Income | 0.00 | 0.00 | ||||
| 6 | Add: Dialysis machine Rental charges | 0.00 | 0.00 | ||||
| 7 | Add: Others | 22.32 | 22.32 | ||||
| Total Profit before tax | 1,703.83 | 1,703.83 | |||||
| i. Finance cost | 3.46 | 3.46 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 1,439.21 | 1,439.21 | |||||
| Profit before tax | 261.16 | 261.16 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Income from IPD Services | 3,418.99 | 3,418.99 | ||||
| 2 | Income from OPD Services | 393.61 | 393.61 | ||||
| 3 | Income from sale of medicines from pharmacy | 654.34 | 654.34 | ||||
| 4 | Add: Profit on Sale of Investment | 0.00 | 0.00 | ||||
| 5 | Add: Interest Income | 0.00 | 0.00 | ||||
| 6 | Add: Dialysis machine Rental charges | 0.00 | 0.00 | ||||
| 7 | Add: Others | 3,147.53 | 3,147.53 | ||||
| Total Segment Asset | 7,614.47 | 7,614.47 | |||||
| Un-allocable Assets | 0.00 | 0.00 | |||||
| Net Segment Asset | 7,614.47 | 7,614.47 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Income from IPD Services | 266.92 | 266.92 | ||||
| 2 | Income from OPD Services | 82.67 | 82.67 | ||||
| 3 | Income from sale of medicines from pharmacy | 864.31 | 864.31 | ||||
| 4 | Add: Profit on Sale of Investment | 0.00 | 0.00 | ||||
| 5 | Add: Interest Income | 0.00 | 0.00 | ||||
| 6 | Add: Dialysis machine Rental charges | 0.00 | 0.00 | ||||
| 7 | Add: Others | 544.44 | 544.44 | ||||
| Total Segment Liabilities | 1,758.34 | 1,758.34 | |||||
| Un-allocable Liabilities | 0.00 | 0.00 | |||||
| Net Segment Liabilities | 1,758.34 | 1,758.34 | |||||
| Disclosure of notes on segments | |||||||
| Whether results are audited or unaudited | Unaudited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | K.K. Chanani & Associates | Yes | 31-07-2029 | ||
|---|---|---|---|---|---|